Yonsei Cancer Center expands use of RayStation
Yonsei Cancer Center expands use of RayStation
RaySearch Laboratories AB (publ) announces that Yonsei Cancer Center in South Korea has placed an additional order for the treatment planning system RayStation®*, further expanding the center’s use of RaySearch software across its advanced radiation therapy operations. The order was received in the second quarter of 2026.
Yonsei Cancer Center, part of Yonsei University Health System, has been a RaySearch customer for several years and utilizes RayStation for photon and carbon ion treatment planning, as well as RayCare for oncology information management. The center has played a pioneering role in the adoption of RaySearch solutions in the Asia-Pacific region, becoming the first clinic in the region to adopt RayCare and launch clinical operations with RayCare for carbon ion therapy in 2023.
The new order comprises additional RayStation licenses and modules that further expand Yonsei’s existing RaySearch environment, supporting increasing patient volumes and enabling efficient workflows across treatment planning and oncology information management in advanced radiation therapy. It also includes the recently launched LET optimization functionality, providing advanced capabilities for biological optimization in particle therapy.
“This expansion will support our continued focus on high-quality cancer care and help us deliver efficient treatment for a growing number of patients with complex treatment needs,” says Woong Sub Koom, Director, Yonsei Cancer Center.
“Yonsei is a long-standing leader in advanced radiation therapy, and we are pleased to support the center as it continues to expand its clinical operations and adopt increasingly advanced capabilities,” says Johan Löf, founder and CEO of RaySearch Laboratories.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB
Tel: +46 (0) 8 510 530 00
Carolina Strömlid, Head of Investor Relations, RaySearch Laboratories AB
Tel: +46 (0) 708 807 173
ir@raysearchlabs.com
About Yonsei Cancer Center
Founded in 1969 as South Korea's first dedicated cancer center, Yonsei Cancer Center is a leading institution in cancer care, research, and innovation. Building on decades of clinical excellence and international collaboration, the center aims to strengthen its position as a leading cancer center in Asia and globally. Yonsei Cancer Center is recognized for its evidence-based approach to treatment and for pioneering advanced technologies, including Korea's first robotic surgical system in 2005 and Asia's first robotic IMRT program in 2013.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure, and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. RaySearch’s software has been sold to over 1,200 clinics in 51 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003 (STO: RAY B). More information is available at raysearchlabs.com.
Learn more about us on:
LinkedIn
YouTube
* Subject to regulatory clearance in some markets.